COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,726 Articles (22,502 medRxiv, 8,224 bioRxiv)

Most recent first Previous |  Page 874: Articles 8731-8740  | Next

SARS-CoV-2 variants of concern Alpha and Delta show increased viral load in saliva
King, K. L., Wilson, S., Napolitano, J. M., Sell, K. J., Rennert, L., Parkinson, C. J., Dean, D.
10.1101/2022.02.10.22270797 — Posted: 2022-02-15
COVID-19 onset reduced the sex ratio at birth in South Africa
Masukume, G., Ryan, M., Masukume, R., Zammit, D., Grech, V., Mapanga, W.
10.1101/2022.02.07.22270630 — Posted: 2022-02-15
Co-infection with SARS-COV-2 Omicron and Delta Variants Revealed by Genomic Surveillance
Rockett, R. J., Draper, J., Gall, M., Sim, E. M., Arnott, A., Agius, J. E., Johnson-Mackinnon, J., Martinez, E., Drew, A. P., Lee, C., Ngo, C., Ramsperger, M., Ginn, A. N., Wang, Q., Fennell, M., Ko, D., Huston, L., Kairaitis, L., Holmes, E. C., O'Sullivan, M. N., Chen, S. C.-A., Kok, J., Dwyer, D. E., Sintchenko, V.
10.1101/2022.02.13.22270755 — Posted: 2022-02-15
Favipiravir, lopinavir-ritonavir or combination therapy (FLARE): a randomised, double blind, 2x2 factorial placebo-controlled trial of early antiviral therapy in COVID-19
Lowe, D. M., Brown, L.-A. K., Chowdhury, K., Davey, S., Yee, P., Ikeji, F., Ndoutoumou, A., Shah, D., Lennon, A., Rai, A., Agyeman, A. A., Checkley, A., Longley, N., Dehbi, H.-M., Freemantle, N., Breuer, J., Standing, J. F., FLARE Investigators
10.1101/2022.02.11.22270775 — Posted: 2022-02-15
Users' Reactions on Announced Vaccines against COVID-19 Before Marketing in France: Analysis of Twitter posts
Dupuy-Zini, A., Audeh, B., Gagneux-Brunon, A., Bousquet, C.
10.1101/2022.02.14.22268832 — Posted: 2022-02-15
Diagnostic Accuracy of Commercially Available Tests for Respiratory Syncytial Virus: A Scoping Literature Review in the COVID-19 Era
Bernstein, D. I., Mejias, A., Rath, B., Woods, C. W., Philips Deeter, J.
10.1101/2022.02.14.22270927 — Posted: 2022-02-15
Direct and indirect mortality impacts of the COVID-19 pandemic in the US, March 2020-April 2021
Lee, W.-E., Woo Park, S., Wienberger, D. M., Olson, D., Simonsen, L., Grenfell, B. T., Viboud, C.
10.1101/2022.02.10.22270721 — Posted: 2022-02-15
SARS-CoV-2 IgG seroprevalence in blood donors located in three different federal states, Germany, July 2020 to June 2021-a follow-up
Fischer, B., Vollmer, T., Knabbe, C.
10.1101/2022.02.11.22270833 — Posted: 2022-02-15
Source terms for benchmarking models of SARS-CoV-2 transmission via aerosols and droplets
Stettler, M. E. J., Nishida, R. T., de Oliveira, P. M., Mesquita, L., Johnson, T., Galea, E., Grandison, A., Ewer, J., Carruthers, D., Kumar, P., Avital, E., Obeysekara, A., Doorly, D., Hardalupas, Y., Green, D., Coldrick, S., Parker, S., Boies, A.
10.1101/2022.02.11.22270844 — Posted: 2022-02-15
Demographic Characteristics and Clinical Features of COVID-19 Patients Admitted in a Combined Military Hospital of Bangladesh
Mahboob, S., Johora, F., Abbasy, A. A., Jeenia, F. T., Ali, M., Naharin, N. E., Ferdoush, J.
10.1101/2022.02.12.22270893 — Posted: 2022-02-15

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).